Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics

BACKGROUND Maintaining gastrointestinal (GI) microbiome diversity plays a key role during allogeneic stem cell transplantation (ASCT), and loss of diversity correlates with acute GI graft versus host disease (GvHD) and poor outcomes. METHODS In this retrospective analysis of 161 ASCT patients, we used serial analyses of urinary 3-indoxyl sulfate (3-IS) levels and GI microbiome parameters within the first 10 days after ASCT to identify potential commensal microbiota-sparing antibiotics. Based on antibiotic activity, we formed 3 subgroups (Rifaximin without systemic antibiotics, Rifaximin with systemic antibiotics, and Ciprofloxacin/Metronidazole with/without systemic antibiotics). RESULTS Mono-antibiosis with Rifaximin revealed higher 3-IS levels (P < .001), higher Clostridium cluster XIVa (CCXIVa) abundance (P = .004), and higher Shannon indices (P = .01) compared to Ciprofloxacin/Metronidazole with/without systemic antibiotics. Rifaximin followed by systemic antibiotics maintained microbiome diversity compared to Ciprofloxacin/Metronidazole with/without systemic antibiotics, as these patients showed still higher 3-IS levels (P = .04), higher CCXIVa copy numbers (P = .01), and higher Shannon indexes (P = .01). Even for this larger cohort of patients, the outcome was superior with regard to GI GvHD (P = .05) and lower transplant-related mortality (P < .001) for patients receiving Rifaximin plus systemic antibiotics compared to other types of systemic antibiotic treatment. Antibiosis with Ciprofloxacin/Metronidazole (n = 12, P = .01), Piperacillin/Tazobactam (n = 52, P = .01), Meropenem/Vancomycin (n = 16, P = .003), Ceftazidime (n = 10, P = .03), or multiple systemic antibiotics (n = 53, P = .001) showed significantly lower 3-IS levels compared to mono-antibiosis with Rifaximin (n = 14) or intravenous Vancomycin (n = 4, not statistically significant). CONCLUSIONS Different types of antibiotic treatments show different impacts on markers of microbiome diversity. The identification of antibiotics sparing commensal bacteria remains an ongoing challenge. However, Rifaximin allowed a higher intestinal microbiome diversity, even in the presence of systemic broad-spectrum antibiotics.

[1]  W. Wood,et al.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  M. V. D. van den Brink,et al.  Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? , 2017, Blood advances.

[3]  T. Battaglia,et al.  Gut Microbiome and Antibiotics. , 2017, Archives of medical research.

[4]  Melanie R Rutkowski,et al.  The influence of the commensal microbiota on distal tumor-promoting inflammation. , 2017, Seminars in immunology.

[5]  B. Paulweber,et al.  Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. , 2017, Beneficial microbes.

[6]  E. Allen-Vercoe,et al.  Microbial Interactions and Interventions in Colorectal Cancer. , 2017, Microbiology spectrum.

[7]  N. Juge,et al.  Introduction to the human gut microbiota , 2017, The Biochemical journal.

[8]  P. Oefner,et al.  Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  R. Jenq,et al.  Clinical Evidence for the Microbiome in Inflammatory Diseases , 2017, Front. Immunol..

[10]  C. Bernardazzi,et al.  Diet and microbiota in inflammatory bowel disease: The gut in disharmony , 2017, World journal of gastroenterology.

[11]  D. Enot,et al.  The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation , 2017, Oncoimmunology.

[12]  M. Hattori,et al.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. , 2016, Blood.

[13]  S. Esposito,et al.  Microbiota and neurologic diseases: potential effects of probiotics , 2016, Journal of Translational Medicine.

[14]  Ben Nichols,et al.  Distributed under Creative Commons Cc-by 4.0 Vsearch: a Versatile Open Source Tool for Metagenomics , 2022 .

[15]  A. Gessner,et al.  Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. , 2016, International journal of medical microbiology : IJMM.

[16]  U. Şahin,et al.  An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[17]  Y. Taur,et al.  Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice , 2016, Science Translational Medicine.

[18]  P. Oefner,et al.  Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation , 2016, Bone Marrow Transplantation.

[19]  A. Gasbarrini,et al.  The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin , 2016, Digestive Diseases.

[20]  H. DuPont,et al.  Review article: the antimicrobial effects of rifaximin on the gut microbiota , 2016, Alimentary pharmacology & therapeutics.

[21]  Daniel Wolff,et al.  Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. , 2015, Blood.

[22]  Y. Taur,et al.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  M. Vetizou,et al.  Cancer and the gut microbiota: An unexpected link , 2015, Science Translational Medicine.

[24]  A. Gasbarrini,et al.  Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin. , 2015, Mini reviews in medicinal chemistry.

[25]  M. Blaser.  The microbiome revolution. , 2014, The Journal of clinical investigation.

[26]  A. Viale,et al.  The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. , 2014, Blood.

[27]  D. Livermore,et al.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia , 2013, Haematologica.

[28]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[29]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[30]  A. Viale,et al.  Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis , 2011, Infection and Immunity.

[31]  N. Socci,et al.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.

[32]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[33]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[34]  A. Gasbarrini,et al.  Rifaximin pharmacology and clinical implications , 2009, Expert opinion on drug metabolism & toxicology.

[35]  A. Neish,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Microbes in Gastrointestinal Health and Disease , 2009 .

[36]  G. Holtrop,et al.  Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii , 2008, British Journal of Nutrition.

[37]  W. Ludwig,et al.  SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.

[38]  Sang Joon Kim,et al.  A Mathematical Theory of Communication , 2006 .

[39]  A. Palva,et al.  Development of an extensive set of 16S rDNA‐targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real‐time PCR , 2004, Journal of applied microbiology.

[40]  A. Elmaagacli,et al.  Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospect , 1999, Blood.

[41]  C E Shannon,et al.  The mathematical theory of communication. 1963. , 1997, M.D. computing : computers in medical practice.

[42]  D. van der Waaij,et al.  Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. , 1974, Journal of the National Cancer Institute.